VS-024

N/A

Report date: 2025/03/12 16:39:02
NME

Base Information

Drug NameVS-024
Drug Alias NameVS024
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionEpithelial sodium channel modulatorsSolute carrier family 26 member 9 modulatorsMucin-5AC modulators
TargetsEpithelial sodium channelSolute carrier family 26 member 9Mucin-5AC
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida Research Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesNuvara Therapeutics
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A